PF-Atlas › Clinical Trials › NCT00117208
Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis
mannitol · Phase 2
Registry ID
NCT00117208
Phase
Phase 2
Status
Completed
Drug / intervention
mannitol
Sponsor
Syntara
Start
2005-11
About this trial
mannitol is evaluated in NCT00117208, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Syntara. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00117208 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.